Results 61 to 70 of about 484,803 (330)
Journal of Korean medical science, 2020 Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections.
J. Ahn +18 more
semanticscholar +1 more source
Advanced Materials Interfaces, EarlyView.This study confirms that extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) or HEK293F cells overexpressing CD24 have anti‐inflammatory effects in macrophages and monocytes. Further loading either of these EVs with an anti‐Myd88 peptide synergistically enhanced the anti‐inflammatory effects of the EVs.
Burçin İrem Abas +6 more
wiley +1 more source
Revealing Cell‐Free Mitochondrial DNA Breakage Patterns as Novel Biomarkers for Sepsis
Advanced Science, EarlyView.Uncovering distinct plasma cfmtDNA breakage patterns opens new frontiers for early sepsis detection and prognosis. Unique cleavage hotspots in RNR2 and COX2 regions outperform traditional biomarkers, while mechanistic insights suggest bacterial endonuclease involvement.
Haitang Liao +13 more
wiley +1 more source
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
New England Journal of Medicine, 2019 BACKGROUND The benefits of early continuous neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS) who are receiving mechanical ventilation remain unclear.
M. Moss +19 more
semanticscholar +1 more source
MANAGEMENT OF RESPIRATORY DISTRESS SYNDROME
British Journal of Anaesthesia, 1977 Respiratory Distress Syndrome is a name given to a disease affecting newborn babies, especially those born before term. Its full title is "idiopathic respiratory distress syndrome of the newborn", and it is also called "hyaline membrane disease", a title which carries the assumption that, should the lung become available for histology, hyaline ...
J W Scopes
openalex +4 more sources
Frontiers in Immunology, 2020 Citation: Girija ASS, Shankar EM and Larsson M (2020) Could SARS-CoV-2-Induced Hyperinflammation Magnify the Severity of Coronavirus Disease (CoViD-19) Leading to Acute Respiratory Distress Syndrome? Front. Immunol. 11:1206. doi: 10.3389/fimmu.2020.01206
L. F. V. Dyk +3 more
semanticscholar +1 more source
Advanced Science, EarlyView.Here, a decision‐making mechanism underlying mechanical adaptation is demonstrated. This study demonstrates that cellular adaptation to mechanical stress can be induced by applying low‐amplitude stretch to cells. When the stretch reaches a critical amplitude threshold, it triggers Ca2⁺‐dependent positive feedback, which induces cholesterol efflux and ...
Zhengyan Wang +21 more
wiley +1 more source
Archives of Medical Science, 2020 Introduction The comparative efficacy of pulmonary surfactant in the treatment of respiratory distress syndrome in preterm infants remains unclear. We aimed to evaluate the effectiveness of different pulmonary surfactant in the treatment of respiratory ...
Caihong Qiu +4 more
doaj +1 more source
Effectiveness of noninvasive ventilation in COVID‐19 related‐acute respiratory distress syndrome
Clinical Respiratory Journal, 2021 During this long COVID‐19 pandemic outbreak, continuous positive airway pressure (CPAP) and noninvasive ventilation (NIV) are being widely used to treat patients with moderate to severe acute respiratory failure (ARF). As for now, data on the efficacy of
F. Menzella +15 more
semanticscholar +1 more source
The NSP5, ORF6 and NSP13 of SARS‐CoV‐2 Cooperate to Modulate Inflammatory Cell Death Activation
Advanced Science, EarlyView.ZBP1 is capable of initiating a large cell death complex to induce programmed cell death during SARS‐CoV‐2 infection. However, SARS‐CoV‐2 can inhibit the activation of ZBP1‐mediated cell death by targeting key components of this complex. This suppression of ZBP1‐mediated cell death may account for the increased mortality observed in patients co ...
Huan Wang +16 more
wiley +1 more source